Normal view
Epigenetics and the Arts Lover
Study Finds a Surprising Link Between Gut Microbes and Aging
Tennis May Add Nearly 10 Years to Your Life and Most People Are Ignoring It
Uncovering Human Lifespan Limits | The Role of Somatic Mutations


Can This New Enzyme Turn Back the Clock in Bodily Tissues?
- ZME Science
- How Long Could Humans Live If We Cured Aging? People Might Live to 200 Years Before DNA Damage Kills Them
Brain Breakthrough Could Help Older Adults Live Longer and Stay Steady
A Slowly Aging Butterfly Could Help Scientists Understand Longevity
A butterfly that survives for nearly a year, while its closest relatives live only two weeks, offers a potential model for studying how aging and lifespan can evolve in nature.
A University of Bristol-led study published in Nature Communications reports that some Heliconius butterflies have evolved both longer lifespans and slower physical decline, distinguishing them from most other butterfly species studied to date.
Heliconius butterflies inhabit the rainforests of Central and South America, where most adult butterflies live only a few weeks. In the study, Heliconius hewitsoni reached a maximum lifespan of 348 days, while a related species, Dione juno, only survived about 14 days under observed conditions. This represents a 25-fold difference in maximum lifespan between two closely related species.
Old Age Without the Decline
Heliconius butterflies not only live longer than their relatives, but also show slower physical decline with age. The team, in collaboration with the Smithsonian Tropical Research Institute in Panama, measured grip strength in aging butterflies to assess physical decline. Older Heliconius hecale performed as well as the younger individuals tested, showing no detectable age-related decline in grip strength.
The team combined butterfly house data, mark–recapture field studies, and controlled lab experiments. In these cases, Heliconius butterflies consistently showed longer lifespans, lower mortality rates, and slower rates of aging than closely related species that do not feed on pollen.
The Pollen Connection
One hypothesis for their extended lifespan focuses on their unusual adult diet. While most butterflies feed only on nectar, Heliconius also consumes pollen, which was thought to provide the nutritional basis for its extended lifespan.
To test this idea, researchers compared pollen-feeding Heliconius hecale with its non-pollen-feeding relative, Dryas iulia. H. hecale maintained body mass and muscle performance longer than D. iulia. Even without pollen in its diet, H. hecale still outlived its relative by a wide margin. This suggests that diet alone does not explain Heliconius’s extended lifespan.
Dr. Jessica Foley, the study’s lead author from the University of Bristol’s School of Biological Sciences, explained that insects already show a huge range of lifespans. Some, like mayflies, live only a few days, while ant and termite queens can survive for decades. “This represents a roughly 5,000-fold difference within the class, compared with around a 100-fold difference in lifespan observed in mammals.”
Heliconius butterflies are notable because they have evolved both longer lifespans and slower rates of aging, allowing them to outlive close relatives from which they diverged only recently in evolutionary history.
A New Model for an Old Problem
Most aging research uses a limited set of laboratory organisms, such as mice, worms, and fruit flies, to study biological aging mechanisms. The heliconius butterfly provides a unique opportunity to study a long-lived species closely related to short-lived species, allowing for direct comparison in a natural context. Foley noted that comparing these two groups “can help reveal how lifespan is extended, making them a highly promising new model for research into the biology of aging and longevity.”
If pollen feeding and longevity evolved together but are not entirely dependent on each other, the next step is to identify the genetic and physiological changes responsible for both traits. Understanding these mechanisms in Heliconius butterflies could provide insight into how aging evolves across species.
Austin Burgess is a writer and researcher with a background in sales, marketing, and data analytics. He holds an MBA, a Bachelor of Science in Business Administration, and a data analytics certification. His work focuses on breaking scientific developments, with an emphasis on emerging biology, cognitive neuroscience, and archaeological discoveries.
Secret to Heliconius Butterflies’ Longevity May Be Hidden in Pollen
Entomologists have compiled decades of data from butterfly houses, wild field studies, and lab experiments to build the most comprehensive picture yet of how long Heliconius butterflies live and how slowly they age.
The post Secret to Heliconius Butterflies’ Longevity May Be Hidden in Pollen appeared first on Sci.News: Breaking Science News.
A Massive 30-Year Study Found the Strength Training Sweet Spot Linked to Living Longer
New Study Seeks to Prolong Immune System Longevity
In a groundbreaking advance poised to transform the landscape of age-related immune decline, University College London (UCL) researchers are spearheading a pioneering clinical trial aimed at rejuvenating worn-out T cells through an innovative immune restoration therapy. This Phase 1 first-in-human study will explore the therapeutic potential of metabolically resetting exhausted or senescent T cells, a subset of immune cells that accumulate with age and chronic disease and lose their robustness in coordinating immune responses. The initiative promises to reopen avenues for combating a spectrum of diseases, including cancer, HIV, and neurodegenerative disorders like dementia, by profoundly modifying the immune system’s intrinsic capacity to defend and repair.
Central to the research is the recognition that immune ageing, characterized by the progressive dysfunction and decline in immune cell performance, is a key factor leading to increased vulnerability in the elderly and those with chronic infections. T cells, particularly the CD4+ subtype—often regarded as the conductors of the immune orchestra—become less effective with time, diminishing the immune system’s ability to coordinate defenses accurately. These cells, rendered senescent or exhausted, exhibit impaired proliferation, cytokine production, and cytotoxic activity, undermining responses to pathogens, malignancies, and cellular damage.
The novel therapy, developed by SenTcell, a biotech startup founded by Dr. Alessio Lanna from UCL Medicine, employs a liquid formulation administered intramuscularly akin to conventional vaccines. This delivery method facilitates patient-friendly administration while targeting key metabolic pathways within dysfunctional T cells. By reprogramming the intracellular environment of these immune cells, the treatment aims to restore youthful functional properties, including enhanced proliferative capacity and efficient pathogen recognition, thereby revitalizing the immune system’s broad protective functions.
Dr. Lanna explains that although antiretroviral advancements have significantly improved lifespans for individuals living with HIV, many still experience premature immune ageing. Similar patterns of immune exhaustion are also detected in cancer patients and other chronic disease cohorts. The imminent clinical trial represents a critical stepping stone towards verifying whether exhausted immune cells can be safely and effectively rejuvenated in human subjects, with the potential to redefine therapeutic paradigms for diseases rooted in immune dysregulation.
At the molecular level, one of the intriguing aspects under investigation involves the role of telomeres—protective caps on chromosome ends whose shortening serves as a hallmark of biological ageing. Laboratory studies have suggested that rejuvenated CD4+ T cells may release telomere-containing extracellular structures, whimsically termed “telomere Rivers,” into the bloodstream. The presence and behavior of these structures might offer novel insights into how restored immune cells influence systemic health, extending their benefits beyond immediate immune niches to broader tissue health. Although this phenomenon has yet to be validated in human clinical contexts, it highlights the sophisticated interplay between immune rejuvenation and organismal aging.
The clinical trial enjoys regulatory support from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) through its Innovative Licensing and Access Pathway (ILAP), underscoring the therapy’s potential to meet the pressing unmet medical needs associated with immune senescence. This endorsement accelerates development timelines and affirms the significance of targeting immune metabolic dysfunction as a viable therapeutic strategy.
Participants in the upcoming Phase 1 trial will be meticulously selected adults exhibiting characteristics of immune dysfunction, including evidence of premature immune ageing or persistent viral infections. Comprehensive immune profiling will be conducted before and after therapeutic administration to discern immunological changes and safety outcomes. Although the initial focus is on evaluating biological activity and tolerability, successful results could pave the way for advanced trials assessing clinical efficacy.
Unlike conventional treatments that combat diseases by targeting individual pathogens or tumor cells directly, this therapy seeks to recalibrate the immune system itself—restoring its intrinsic resilience and regenerative functionality. Such a paradigm shift holds profound implications; by enhancing the immune system’s natural defensive repertoire, it may afford broad-spectrum protection and facilitate healthier ageing trajectories.
Beyond chronic infections like HIV and cancer, this approach could ultimately apply to autoimmune disorders characterized by immune exhaustion, wherein overly active yet dysfunctional immune cells drive pathology. Immune rejuvenation strategies offer a novel means of restoring balance without broadly suppressing immune activity, potentially mitigating disease progression while improving quality of life.
This research aligns with a growing global focus on understanding the cellular and molecular underpinnings of ageing and immune decline. By intervening at the level of T cell metabolism and function, scientists hope to extend not only lifespan but healthspan—preserving cognitive and physical function while reducing susceptibility to infections, cancer, and degenerative diseases.
As UCL celebrates two centuries of academic excellence and innovation, this project embodies the institution’s commitment to translating bold scientific ideas into therapies capable of reshaping medicine. If validated through clinical trials, this immune rejuvenation therapy could herald a transformative era in treating age-associated diseases, offering hope for millions affected by immune dysfunction worldwide.
Subject of Research: People
Article Title: Immune Rejuvenation: UCL’s Pioneering Trial Targets T Cell Exhaustion to Combat Age-Related Immune Decline
News Publication Date: Not provided
Web References: www.ucl.ac.uk
References: Not provided
Image Credits: Not provided
Keywords: Immune ageing, T cell exhaustion, CD4+ T cells, immune rejuvenation, senescent immune cells, telomeres, immune dysfunction, chronic disease, HIV, cancer, metabolic resetting, Phase 1 clinical trial
- Science Mag
- “Geriatric” Butterfly Species Lives Almost Three Times Longer Than Its Relatives, Study Finds
“Geriatric” Butterfly Species Lives Almost Three Times Longer Than Its Relatives, Study Finds
In the dense, vibrant rainforests stretching across South and Central America, a remarkable evolutionary marvel is unfolding in the form of a tropical butterfly genus that defies traditional biological limits on lifespan. According to a groundbreaking study led by researchers at the University of Bristol, as published recently in Nature Communications, Heliconius butterflies have evolved a sophisticated anti-aging mechanism that dramatically extends their lifespans compared to their close relatives. This discovery not only challenges existing paradigms surrounding insect longevity but also opens a new frontier in understanding the molecular and physiological bases of aging in natural populations.
Heliconius butterflies, widely distributed throughout neotropical ecosystems, have long intrigued biologists due to their exceptional longevity. Unlike most butterfly species, which complete their adult phase within a few weeks, Heliconius butterflies exhibit lifespans that soar to nearly a full year, with median lifespans averaging around three times those of closely related species. Specifically, Heliconius hewitsoni can live up to 348 days in the wild, a staggering contrast to the mere 14 days observed in its relative Dione juno. This magnified difference—in terms of maximum lifespan—exceeds a 25-fold disparity, presenting a natural laboratory to investigate the factors that contribute to longevity.
Delving into the evolutionary dynamics behind this phenomenon, the research team employed an integrative methodology that combined field observations, controlled insectary experiments, and mark-release-recapture studies across multiple Heliconiini tribe species. This multifaceted approach allowed the scientists to quantify not only lifespan but also the patterns of physiological aging, including metrics such as physical performance decline via grip-strength assessments. Intriguingly, in some Heliconius species like Heliconius hecale, the expected decline in physical capabilities that accompanies aging in most organisms was virtually absent, underscoring an evolved resistance to senescence.
The research highlights a unique ecological adaptation: adult pollen feeding. Heliconius butterflies are one of the few lepidopteran groups capable of digesting pollen throughout their adult lives, contrasting with the nectar-reliant feeding habits of most butterflies. This dietary specialization appears intricately linked to their extended healthspan and longevity. Pollen is a rich source of proteins and amino acids, which are hypothesized to support enhanced somatic maintenance and cellular repair mechanisms, potentially underpinning slower rates of aging and sustained physiological function.
To rigorously test the relationship between diet and aging, the study contrasted Heliconius hecale with its non-pollen-feeding relative Dryas iulia under controlled conditions that varied access to pollen. Remarkably, while Heliconius hecale individuals sustained their muscular function and body mass longer and evaded typical age-related deterioration, even those deprived of pollen retained a longevity advantage relative to Dryas. This finding implies that while pollen feeding contributes nutritionally, intrinsic genetic or epigenetic adaptations also play a critical role in extending lifespan, suggesting a complex interplay between evolved traits and ecological factors.
From an evolutionary biology perspective, the divergence in longevity and aging rates within the Heliconiini tribe exemplifies natural selection’s power in shaping life-history traits in response to ecological niches and resource utilization. The accelerated lifespan and delayed senescence in Heliconius suggest that adaptive shifts—such as adult pollen feeding—can drive profound modifications in physiology and perhaps modulate molecular pathways linked to aging, including oxidative stress resistance, protein homeostasis, and metabolic regulation.
The implications of this research extend beyond the entomological sphere, offering a promising model for the biology of aging and lifespan extension. Insects have already revealed fundamental insights into genetic regulation and cellular processes, and the Heliconius genus introduces a new dimension by combining extraordinary longevity with ecological and evolutionary relevance. Decoding the molecular mechanisms enabling Heliconius butterflies to circumvent typical aging processes could illuminate targets for biomedical research into human healthspan and age-related diseases.
Jessica Foley, the study’s lead author, emphasized the significance of these findings within the broader context of longevity research. Highlighting the vast interspecies disparity in lifespan—from ephemeral mayflies surviving mere days to ant and termite castes living decades—she notes that Heliconius butterflies offer a naturally evolved system to decode the underlying biology that governs such diversity. Their relatively recent evolutionary divergence from short-lived relatives strengthens the value of this natural comparative experiment.
Furthermore, the study underscores the utility of integrating ecological, physiological, and evolutionary data to unravel complex biological phenomena. By blending fieldwork with laboratory precision, the researchers were able to identify robust patterns of aging and performance that are rarely accessible in wild insect populations. This holistic approach models a pathway forward for future studies aimed at dissecting the multifactorial influences on longevity and healthspan.
In conclusion, the revelation that Heliconius butterflies not only live exceptionally long lives but also maintain functional integrity well into old age represents a profound breakthrough in understanding natural aging mechanisms. Their case underscores how dietary innovations and evolutionary pressures can collectively sculpt lifespan, challenging the limits traditionally imposed by physiology. As research progresses, the Heliconius genus is poised to emerge as a vital model system, shedding light on the deep evolutionary roots of ageing and longevity and potentially inspiring novel therapeutic approaches for age-associated conditions in humans.
Subject of Research: Animals
Article Title: Evolution of increased longevity and slowed ageing in a genus of tropical butterfly
News Publication Date: 16-Jun-2026
Web References: 10.1038/s41467-026-73635-7
Image Credits: Louise Bestea
Keywords: Insects, Lepidoptera, Rainforests, Tropical forests, Evolutionary biology
Plant-based eating may reduce inflammation, new research suggests
- The Debrief
- This Deep-Sea Predator Can Live for Centuries—Now Geneticists Are Close to Hacking the Secrets of Its Longevity
This Deep-Sea Predator Can Live for Centuries—Now Geneticists Are Close to Hacking the Secrets of Its Longevity
The mystery of the Greenland shark’s incredible longevity may finally be unraveling, as a team of international researchers has completed the first comprehensive genome map of the creature.
Native to the cold waters between Greenland, Iceland, and Canada, Greenland sharks boast one of the longest vertebrate lifespans on Earth, approaching 400 years. In a recent paper published in the Proceedings of the National Academy of Sciences, researchers led by Shigeharu Kinoshita of the University of Tokyo have identified some of the genetic basis of that extraordinary lifespan, which they say future researchers may exploit to treat cancer and age-related illnesses.
Greenland Sharks Longevity
As genetic sequencing technology has improved and costs have fallen, there has been a major increase in the number of sequences from long-lived species for comparative analysis. Discoveries have included identifying increases in genes related to the immune system and growth hormone receptors in rockfish and bat species noted for their longevity.
With an entire lifecycle in slow motion, Greenland sharks’ longevity can be traced to their prolonged development: they take 150 years to reach sexual maturity, growing only 1 centimeter per year. Despite being one of the slowest swimmers in the ocean, the species undertakes large-scale migrations spanning over 1,000 kilometers.
Genome Mapping
Large genome sizes, like those of the Greenland shark, pose enormous mapping challenges, full of many repetitive sequences. Despite their importance for management and conservation, few whale and shark species have been sequenced due to the difficulty involved. To fill data gaps in the genetic causes of longevity, aquatic species evolution, and the risks of biodiversity loss, the team chose the Greenland shark as their subject.
The University of Tokyo-led team mapped roughly 5.9 billion DNA base pairs, accounting for 96.7% of the shark’s genome. Among the discoveries were the identification of specific genetic features likely related to the Greenland shark’s longevity.
In their paper, they wrote of discovering “genetic traits associated with cancer, immune response function, genome stability, and cardiac function, deep-sea adaptations, and population size dynamics,” in the new research.
Longevity Results
One of the most crucial of these traits is how the shark appears to mitigate the genetic strain that contributes to aging by stabilizing the building blocks of chromosomes. Chromatin is a structure consisting of DNA, RNA, and proteins, which makes up chromosomes.
In the Greenland shark, the histone H1.0 protein, which binds DNA in chromatin, undergoes an amino acid substitution that may enhance stability and reduce the effects of aging.
Another genetic tool aiding the shark’s longevity is the presence of 59 copies of the FTH1b gene, which researchers discovered on pseudochromosome 33, far above the number seen in other shark or fish species. This helps regulate ferroptosis, a form of programmed cell death, thereby mitigating cell damage. Since the gene controls iron storage and ferroptosis is iron-dependent, the researchers say this multiplication of FTH1b could prevent oxidative cell damage.
Beyond those specific expressions, researchers also found expansion of entire gene families associated with DNA repair, immune functions, and cancer resistance.
Although limited to a single species, the research does advance general understanding of the genetic factors involved in extended lifespans. However, it will be up to future researchers to identify how this new information can be applied to human concerns.
The paper, “The Greenland Shark Genome: Insights into Lifespan Extremes and Population Dynamics,” appeared in Earth and Planetary Science Letters on May 19, 2026.
Ryan Whalen covers science and technology for The Debrief. He holds an MA in History and a Master of Library and Information Science with a certificate in Data Science. He can be contacted at ryan@thedebrief.org, and follow him on Twitter @mdntwvlf.